The global kidney function tests market is expected to reach USD 1.9
billion by 2025, according to a new study by Grand View Research, Inc. The
growing prevalence of Chronic Kidney Diseases (CKD) and renal failure is
presumed to be responsible for the high urgency to use kidney function tests,
which is anticipated tobroaden the scope for growth throughout the forecast
period. In addition, expanding base of diabetic population, which is highly
susceptible to the aforementioned diseases, is predicted to impel the demand
further over the coming years. Consequently, resultant high sample volume will
require high capability kidney function testing devices, which is believed to
present the market with significant growth potential opportunities.
 |
North America kidney function tests market, by product, 2014
- 2025 (USD Million)
|
In addition, growing awareness with respect to diagnostic benefits
associated with kidney function tests is also anticipated to be one of the high
impact rendering drivers for this market. Emergence of technologically advanced
products, such as automated analyzers, has led to refinement of current
real-time point-of-care testing capabilities and, therefore, creates lucrative
growth opportunities for the market. Furthermore, presence of public as well
private healthcare organizations consistently striving to support diagnosis and
management of CKD through a range of programs and initiatives is expected to
create potential demand.
In depth research report on Kidney Function Tests Market
Further key findings from the study suggest:
·
Imaging tests are expected to exhibit lucrative CAGR owing
to increasing adoption in wide array of clinical applications. The high
penetration can be attributed to efficient renal function risk assessment due
to abnormal results generated through other tests
·
Diagnostic laboratories are anticipated to exhibit
lucrative CAGR during the forecast period owing to increasing preference for
point-of-care testing by clinicians
·
In 2016, North America held a dominant share of the global
kidney function tests market, as a consequence of increasing local presence of
prominent companies undertaking competitive sustainability strategies
·
Asia Pacific is anticipated to grow at an exponential CAGR
owing to unmet needs of patients, continuous infrastructural &
technological upgradation, and increasing healthcare expenditure
·
Some key participants such as Abbott Laboratories; Merck
Millipore; Alere, Inc.; and Quest Diagnostics are implementing various
competitive strategies, such as new product development & frequent product
approvals, to maintain their position in the market
·
For instance, in March 2015, metropolis announced the
launch of a kidney function test, a PLA2R antibody test, that detects and
evaluates intensity of membranous nephropathy
Grand View Research has segmented the kidney function tests market on the
basis of product, end use, and region:
Kidney Function Tests
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Dilution & Concentration Tests
·
Clearance Tests
·
Urine Tests
·
Imaging Tests
Kidney Function Tests
End-Use Outlook (Revenue, USD Million, 2014 - 2025)
·
Hospitals
·
Diagnostic Laboratories
·
Academic Research Laboratories
·
Others
Kidney Function Tests
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
o
India
·
Latin America
o
Mexico
o
Brazil
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
For more market analysis
reports, please visit:
No comments:
Post a Comment